Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The effect of secukinumab on moderate-to-severe scalp psoriasis: results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study
The peptides ability to accelerate transition from inflammatory to proliferative healing phases may limit the duration of pro-fibrotic signaling
Avoid repeated freeze-thaw cycles of reconstituted solutions, as temperature fluctuations may lead to peptide degradation and reduced biological activity
W.Lopez-DiazF
Research timelines vary by compound and model, so there is no fixed figure
Response was durable for a median of 9.5 months in the lower dosing group
US$ 20.69
US$ 22.20
US$ 23.55
US$ 25.29
US$ 24.97
US$ 28.63
US$ 27.41
US$ 21.81
